Want to see IN:VISHNU full AI Analyst Report?
Top Page
Vishnu Chemicals Limited
(VISHNU)
Select Model
Select Model
Rating:62Neutral
Price Target:
₹744.00
▲(16.87% Upside)
Action:Reiterated
Date:09/06/26
The score is primarily held back by weak cash generation and sustained negative free cash flow despite solid reported profitability, which increases reliance on funding. Offsetting this, the balance sheet has improved versus prior high-leverage years and the stock shows strong upward technical momentum. Valuation is somewhat demanding at ~31x earnings, but a ~4.3% dividend yield provides support.
Positive Factors
Revenue recovery and profitability
FY2026 revenue rose 6.6% after FY2025 was roughly flat, while EBIT margin was ~13.1%, EBITDA margin ~15.7%, and net margin ~8.8%. This combination shows recovery plus healthy operating economics, supporting reinvestment and earnings resilience if demand remains steady.
Negative Factors
Persistent negative free cash flow
Operating cash flow of ~₹0.93B was below ~₹1.42B of net income in FY2026, while free cash flow was negative in FY2024–FY2026, reaching ~-₹1.64B. Persistent conversion weakness can increase dependence on debt or external funding and constrain growth investment.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue recovery and profitability
FY2026 revenue rose 6.6% after FY2025 was roughly flat, while EBIT margin was ~13.1%, EBITDA margin ~15.7%, and net margin ~8.8%. This combination shows recovery plus healthy operating economics, supporting reinvestment and earnings resilience if demand remains steady.
Read all positive factors
Vishnu Chemicals Limited (VISHNU) vs. iShares MSCI India ETF (INDA)
Market Cap
₹47.24B
Dividend Yield0.04%
Average Volume (3M)8.13K
Price to Earnings (P/E)31.4
Beta (1Y)0.58
Revenue Growth16.61%
EPS Growth15.18%
CountryIN
Employees464
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)22.29
Shares Outstanding67,315,285
10 Day Avg. Volume14,054
30 Day Avg. Volume8,133
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)3.08
Price to Sales (P/S)2.04
P/FCF Ratio-20.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.5
Revenue Forecast (FY)₹17.92B
Vishnu Chemicals Limited Business Overview & Revenue Model
Company Description
Founded in 1989 and headquartered in Hyderabad, India, Vishnu Chemicals Limited specializes in the manufacturing and global distribution of chromium and barium compounds. The company's extensive product line features various chrome-based chemicals...
How the Company Makes Money
Vishnu Chemicals makes money primarily by manufacturing and selling chromium-based specialty chemicals to industrial customers. Revenue is generated through (i) sales of finished chemical products (notably chromium chemicals such as sodium dichrom...
Vishnu Chemicals Limited Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.94B | 16.10B | 14.47B | 12.09B | 13.88B | 10.66B |
| Gross Profit | 4.15B | 3.99B | 3.58B | 2.93B | 4.93B | 3.86B |
| EBITDA | 2.68B | 2.52B | 2.44B | 2.05B | 2.44B | 1.60B |
| Net Income | 1.50B | 1.42B | 1.27B | 1.01B | 1.37B | 813.93M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 20.88B | 16.34B | 13.25B | 10.51B | 9.15B |
| Cash, Cash Equivalents and Short-Term Investments | 1.00B | 81.03M | 817.44M | 617.07M | 20.93M | 27.99M |
| Total Debt | 0.00 | 5.27B | 3.42B | 3.19B | 3.79B | 3.65B |
| Total Liabilities | -10.75B | 10.13B | 7.07B | 6.24B | 6.37B | 6.38B |
| Stockholders Equity | 10.75B | 10.69B | 9.27B | 7.01B | 4.14B | 2.77B |
Cash Flow | ||||||
| Free Cash Flow | 85.24M | -1.64B | -263.28M | -528.47M | 168.85M | 64.28M |
| Operating Cash Flow | 910.85M | 933.10M | 615.23M | 674.98M | 1.34B | 897.27M |
| Investing Cash Flow | -1.42B | -2.71B | -1.07B | -1.54B | -1.18B | -811.50M |
| Financing Cash Flow | 543.59M | 1.83B | 462.23M | 881.28M | -155.73M | -85.66M |
Vishnu Chemicals Limited Technical Analysis
Positive
636.60
Price Trends
620.77
Positive
607.67
Positive
559.78
Positive
Market Momentum
18.78
Negative
77.73
Negative
77.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VISHNU, the sentiment is Positive. The current price of 636.6 is above the 20-day moving average (MA) of 634.03, above the 50-day MA of 620.77, and above the 200-day MA of 559.78, indicating a bullish trend. The MACD of 18.78 indicates Negative momentum. The RSI at 77.73 is Negative, neither overbought nor oversold. The STOCH value of 77.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VISHNU.
Vishnu Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹59.98B | 43.08 | ― | 0.25% | 91.44% | 19.67% | |
62 Neutral | ₹47.24B | 31.40 | ― | 0.04% | 16.61% | 15.18% | |
60 Neutral | ₹39.28B | 76.33 | ― | 0.06% | 41.09% | 618.16% | |
57 Neutral | ₹25.53B | 16.94 | ― | 0.11% | 19.47% | 11.49% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹47.82B | 38.01 | ― | 0.17% | 5.47% | 24.88% | |
51 Neutral | ₹58.61B | 161.96 | ― | 0.05% | 18.00% | 3.85% |
* General Sector Average
IN:VISHNU
Vishnu Chemicals Limited
701.70
219.58
45.55%
IN:FCL
Fineotex Chemical Limited
51.51
28.12
120.21%
IN:LXCHEM
Laxmi Organic Industries Ltd.
172.05
-40.59
-19.09%
IN:NEOGEN
Neogen Chemicals Ltd.
2,140.50
559.87
35.42%
IN:ROSSARI
Rossari Biotech Ltd
460.90
-154.36
-25.09%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,679.05
697.53
71.07%
Vishnu Chemicals Limited Corporate Events
Vishnu Chemicals Schedules Virtual Analyst and Investor Meetings
Aug 15, 2026
Vishnu Chemicals Limited has scheduled virtual one-on-one meetings with analysts and institutional investors on August 19 and 20, 2026, starting at 4.00 PM IST on both days. These engagements form part of its ongoing investor relations efforts and...
Vishnu Chemicals Sets August 28 Date for Virtual 33rd AGM
Aug 7, 2026
Vishnu Chemicals Limited has announced that its 33rd Annual General Meeting will be held on August 28, 2026, at 11:00 a.m. IST via video conferencing or other audio-visual means. The company has published statutory notices about the AGM and relate...
Vishnu Chemicals Publishes Q1FY27 Investor Presentation
Aug 3, 2026
Vishnu Chemicals Limited has released an investor presentation covering its financial results for the first quarter of FY27, ended June 30, 2026. The presentation, filed with both the BSE and NSE and made available on the company’s website, ...
Vishnu Chemicals Publishes Q1 FY27 Results in Leading Dailies
Aug 3, 2026
Vishnu Chemicals Limited has notified the stock exchanges that it has published newspaper advertisements detailing its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The results were carried in T...
Vishnu Chemicals Delivers 25% Revenue Growth in Q1FY27 on Broad-Based Demand
Aug 2, 2026
Vishnu Chemicals reported a strong start to FY27, posting consolidated operating revenue of ₹433.4 crore for Q1FY27, up 24.9% year-on-year, with EBITDA rising 17.5% and profit after tax increasing 23.0%. Despite a slight sequential moderatio...
Vishnu Chemicals Posts Strong Q1 FY27 Results With Higher Revenue and Profit
Aug 1, 2026
Vishnu Chemicals Limited’s board has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, marking a strong start to the fiscal year. The disclosure, filed with both BSE and NSE and posted ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.